Bergbower Emily A S, Lorico Andrea S, Kaur Kiranjot, Brookman Jason, Weinberg Guy, Onyewu Samuel
Department of Anesthesiology, University of Maryland Medical Center, Baltimore, MD, USA.
Department of Anesthesiology, University of Illinois College of Medicine, Chicago, IL, USA.
J Community Hosp Intern Med Perspect. 2024 Mar 14;14(2):127-131. doi: 10.55729/2000-9666.1315. eCollection 2024.
We describe the case of a 28-year-old man with Brugada syndrome who received single-shot adductor canal and sciatic nerve blocks for the management of post-operative pain related to extensive orthopedic injuries. Low-dose ropivacaine with glucocorticoid additives was administered without any EKG changes, arrhythmias, or syncopal sensations. The patient experienced pain relief for over 24 h and was monitored on telemetry with defibrillator pads as a cardiac precaution. This case adds a valuable data point in the limited canon of information on the safety and efficacy of regional anesthesia in Brugada syndrome for the perioperative physician.
我们描述了一名28岁布加综合征男性患者的病例,该患者接受了单次股内收肌管阻滞和坐骨神经阻滞,以处理与广泛骨科损伤相关的术后疼痛。给予低剂量罗哌卡因加糖皮质激素添加剂,未出现任何心电图改变、心律失常或晕厥感。患者疼痛缓解超过24小时,并作为心脏预防措施使用除颤电极片进行遥测监测。该病例为围手术期医生提供了关于布加综合征区域麻醉安全性和有效性的有限信息规范中的一个有价值的数据点。